Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: The CARMELINA randomized clinical trial - Rosenstock, J; Perkovic, V; Johansen, OE (JAMA, 2019)
doi:10.1001/jama.2018.18269